V
VivaChek
High-quality blood glucose meters to the global market
About VivaChek
VivaChek Biotech (Hangzhou) Co., Ltd. is a Chinese company that specializes in the development, manufacturing, and distribution of medical devices, with a focus on point-of-care diagnostic solutions. The company's primary products are blood glucose monitoring systems, which are designed to be accurate, reliable, and easy to use for individuals with diabetes.
In addition to its core business of blood glucose meters, VivaChek also produces a wider range of diagnostic products. These include multi-function analyzers capable of measuring blood glucose, ketones, and uric acid, as well as lateral flow rapid tests. The company serves a global market, with its products being sold and recognized in numerous countries worldwide. VivaChek's business model appears to be B2B, supplying to distributors and healthcare providers, as well as potentially direct-to-consumer through various channels.
The company leverages technology to enhance its offerings, such as the VivaChek Link Plus 4G blood glucose meter, which enables real-time data transmission to a digital cloud platform for remote monitoring and comprehensive health management.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Hangzhou, China
- Employees
- 55
- Open positions
- None listed
- Dealroom signal
- 68.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Jul 2026 | — | — | Goldport Capital | ↗ |
| SERIES C✓Equity / VC | Dec 2019 | $14M | $57M | Undisclosed | — |
Growth signals
Latest recorded traffic for VivaChek is 930 monthly website visits, up 4.5% over the last three months. VivaChek's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- SGShenZhen GTJA Investment Group
Series B and later1 investor entered at this stage
Goldport Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about VivaChek on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See VivaChek’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.